Bedrocan provide patients, prescribers and researchers across the world with quality-assured medicinal cannabis.
The company works within a market best characterised as volatile, with a potential for rapid change, and within an industry, by comparison to other pharmaceutical products, that is fledgling in status.
Woodbridge Research worked with Bedrocan AU to identify media goals, to help elucidate who Bedrocan is, what Bedrocan does, and where and under what circumstances Bedrocan is doing it.
The swill of information and media attention associated to this issue requires Bedrocan to fully emphasize its research-based developments, and to interact through evidence-based discourse. The infographic below is one example of our approach to illustrating this…
